Philip Chan1, Catriona McLean2, Stephen Chan3, Gerard S Goh4. 1. Department of Radiology, The Alfred Hospital, Victoria, Australia. 2. Department of Pathology, The Alfred Hospital, Victoria, Australia. 3. Department of Pathology, Sunshine Hospital, Victoria, Australia. 4. Department of Radiology, The Alfred Hospital, Victoria, Australia; Department of Surgery, Monash University, Melbourne, Australia.
Abstract
PURPOSE: Irreversible electroporation (IRE) is a nonthermal tumor ablation technique that induces cell apoptosis while preserving extracellular architecture. Surgical clips and embolic agents may lie adjacent to, or within, the target lesion. It is unknown to date if IRE causes degradation to the embolic agents or surgical clips that may have adverse effects to patients. We aimed to examine the effects of the IRE on the morphology of various embolic agents and the effects of these agents to the ablation field using a previously validated vegetal model. METHODS: Metallic surgical clips and various metallic and nonmetallic embolic agents were inserted within the center of the tuber ablation field. Additionally, clips were inserted on the edge and outside the ablation field. One tuber was ablated as a control. Ablation settings were based on previous published experiments. Tubers were imaged with magnetic resonance imaging (MRI) 18-24 hours after ablation and the ablated field dimensions were measured. Nonmetallic embolic agents were examined microscopically by the pathologist. RESULTS: Nonmetallic agents did not affect the ablation pattern. Metallic implants, however, caused arcing of the ablation margins. There was no macroscopic or microscopic degradation to the agents after IRE. CONCLUSION: The ablation zone arced in the presence of surgical clips at the edge or outside the ablation margins; therefore, nearby critical structures may be susceptible to the effects of IRE. Furthermore, there was no physical degradation of the embolic agents or surgical clips, and this may have importance when considering IRE ablation of previously embolized lesions in vivo.
PURPOSE: Irreversible electroporation (IRE) is a nonthermal tumor ablation technique that induces cell apoptosis while preserving extracellular architecture. Surgical clips and embolic agents may lie adjacent to, or within, the target lesion. It is unknown to date if IRE causes degradation to the embolic agents or surgical clips that may have adverse effects to patients. We aimed to examine the effects of the IRE on the morphology of various embolic agents and the effects of these agents to the ablation field using a previously validated vegetal model. METHODS: Metallic surgical clips and various metallic and nonmetallic embolic agents were inserted within the center of the tuber ablation field. Additionally, clips were inserted on the edge and outside the ablation field. One tuber was ablated as a control. Ablation settings were based on previous published experiments. Tubers were imaged with magnetic resonance imaging (MRI) 18-24 hours after ablation and the ablated field dimensions were measured. Nonmetallic embolic agents were examined microscopically by the pathologist. RESULTS: Nonmetallic agents did not affect the ablation pattern. Metallic implants, however, caused arcing of the ablation margins. There was no macroscopic or microscopic degradation to the agents after IRE. CONCLUSION: The ablation zone arced in the presence of surgical clips at the edge or outside the ablation margins; therefore, nearby critical structures may be susceptible to the effects of IRE. Furthermore, there was no physical degradation of the embolic agents or surgical clips, and this may have importance when considering IRE ablation of previously embolized lesions in vivo.
Authors: Robert E Neal; Ryan L Smith; Helen Kavnoudias; Franklin Rosenfeldt; Ruchong Ou; Catriona A Mclean; Rafael V Davalos; Kenneth R Thomson Journal: Cardiovasc Intervent Radiol Date: 2013-08-14 Impact factor: 2.740
Authors: T Peter Kingham; Ami M Karkar; Michael I D'Angelica; Peter J Allen; Ronald P Dematteo; George I Getrajdman; Constantinos T Sofocleous; Stephen B Solomon; William R Jarnagin; Yuman Fong Journal: J Am Coll Surg Date: 2012-06-16 Impact factor: 6.113
Authors: Albert J Smeets; Robbert J Nijenhuis; Willem Jan van Rooij; Leo E H Lampmann; Peter F Boekkooi; Harry A M Vervest; Jolanda De Vries; Paul N M Lohle Journal: J Vasc Interv Radiol Date: 2010-12 Impact factor: 3.464
Authors: Kenneth R Thomson; Wa Cheung; Samantha J Ellis; Dean Federman; Helen Kavnoudias; Deirdre Loader-Oliver; Stuart Roberts; Peter Evans; Christine Ball; Andrew Haydon Journal: J Vasc Interv Radiol Date: 2011-03-25 Impact factor: 3.464
Authors: Christoph Niessen; Ernst Michael Jung; Walter A Wohlgemuth; Benedikt Trabold; Michael Haimerl; Andreas Schreyer; Christian Stroszczynski; Philipp Wiggermann Journal: Korean J Radiol Date: 2013-08-30 Impact factor: 3.500
Authors: Marleen C A M Melenhorst; Hester J Scheffer; Laurien G P H Vroomen; Geert Kazemier; M Petrousjka van den Tol; Martijn R Meijerink Journal: Cardiovasc Intervent Radiol Date: 2015-05-21 Impact factor: 2.740
Authors: Feng Pan; Thuy D Do; Dominik F Vollherbst; Philippe L Pereira; Götz M Richter; Michael Faerber; Karl H Weiss; Arianeb Mehrabi; Hans U Kauczor; Christof M Sommer Journal: Cancers (Basel) Date: 2021-04-22 Impact factor: 6.639